Hematologic Cancer

These guidelines and other documents provide advice for different types of hematologic cancer: non-Hodgkin lymphoma, leukemia, multiple myeloma, Hodgkin lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis.

CAR T-cell Therapy Enrolment

Displaying Guidelines

21 Items

Acute Leukemia Provincial Plan

Document Status: Current
ID: GL-C50-34

Aug 2017

Adult Acute Leukemia Services Plan for the Greater Toronto Area - Recommendations Report

Document Status: Current
ID: GL-C50-02

Jan 2012

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

Complex Malignant Hematology Models of Care: Recommendations for Changes in the Roles and Composition of the Multidisciplinary Team and the Setting of Care to Improve Access for Patients in Ontario – March 2017

Document Status: Current
ID: GL-C50-31

Mar 2017

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Document Status: Current
Version: 1.0

Updated

Jan 2024

Consensus Pathology Recommendations for Complex Malignant Hematology – December 2016

Document Status: Current
ID: GL-C50-28

Dec 2016

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

Document Status: Current
ID: SCT 5

Aug 2013

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Document Status: Current
ID: RR SCT-9
Version: N/A

Jun 2020

Follow-up Care for Survivors of Lymphoma who have Received Curative-Intent Treatment

Document Status: Current
ID: 26-5

Apr 2016

Guidance for Kyphoplasty and Vertebroplasty for Cancer Patients in Ontario: Recommendations Report 2017

Document Status: Current
Version: 2

Oct 2018

Management of Cardiovascular Risk Factors after Stem Cell Transplant

Document Status: Current
Version: 1

Apr 2019

Management of Early-Stage Hodgkin Lymphoma

Document Status: Current
ID: GL 6-20
Version: 2

May 2023